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Abstract
This study evaluates the current conceptualization of selective mutism (SM) as an anxiety disorder in the DSM-5 using a 
meta-analytic approach. In the absence of any systematic assessment of anxiety in the field of SM, we pooled prevalence 
data of comorbid anxiety disorders in a random-effects meta-analysis. On the basis of 22 eligible studies (N = 837), we found 
that 80% of the children with SM were diagnosed with an additional anxiety disorder, notably social phobia (69%). However, 
considerable heterogeneity was present, which remained unexplained by a priori specified moderators. The finding that SM 
is often diagnosed in combination with anxiety disorders, indicates that these disorders are not discrete, separable catego-
ries. Moreover, this finding does not help to elucidate the relation between SM and anxiety as an etiological mechanism or 
symptomatic feature. Broadening our research strategies regarding the assessment of anxiety is paramount to clarify the role 
of anxiety in SM, and allow for proper classification.
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Introduction
Selective mutism (SM) is a psychiatric disorder that is usu-
ally—although not necessarily—diagnosed during child-
hood. According to the latest edition of the Diagnostic 
and Statistical Manual of Mental Disorders (DSM-5 [1]) 
it is characterized by a consistent failure to speak in spe-
cific social situations where there is an expectation for 
speaking (e.g., at school), while the production of speech 
appears to be normal in other situations (e.g., at home). 
Therefore, SM cannot be attributed to a disturbance of lan-
guage development. Nevertheless, the lack of speech usu-
ally interferes with occupational or educational achievement, 
and—obviously—with social communication, thus making 
SM a debilitating disorder. The mean age of onset of SM 
is between 2.7 and 4.6 years [2–5], although the condition 
may go unnoticed until the child enters elementary school 
[6]. SM appears to be slightly more common in girls than in 
boys, with a reported sex ratio between 1:1.2 and 1:2 [7–9]. 
Most attempts to estimate the prevalence of SM have been 
conducted in school-based communities and yielded point 
prevalence rates ranging between 0.03 and 0.79% [4, 10–13]. 
SM is therefore considered to be a relatively rare psychiatric 
disorder [1].
The origin of the concept of SM has often been traced to 
Kussmaul (1822–1902), the German physician still known 
today for Kussmaul’s sign, Kussmaul breathing, and a host 
of non-eponymous terms with ongoing clinical relevance. 
His 1877 pioneering work on speech disturbances offered 
several clinical descriptions of “absence of speech without 
disturbance of speech”, a condition he associated primarily 
with cases of “hysteria and other neuroses” (p. 200) [14]. 
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However, in the literature that followed, a subtle yet oft-
repeated misconception has been that Kussmaul called this 
condition ‘aphasia voluntaria’ (i.e., ‘voluntary inability to 
speak’), a malapropism of the term ‘aphrasia voluntaria’ that 
he actually used, which has the more plausible meaning of 
a ‘voluntary absence of speech’ (p. 211) [14]. Apart from 
introducing this term, Kussmaul positioned aphrasia vol-
untaria among other speech disturbances, thus providing an 
extensive frame of reference for differential diagnosis. Still, 
as indicated by his lavishly referenced book, he was not the 
first and certainly not the last to describe this condition and 
come up with a name for it.
In 1934 another pioneer in the area of speech disorders, 
the Swiss child psychiatrist Tramer (1882–1963), suggested 
elektiver Mutismus as an appropriate term. As he expounded 
in his detailed case report of a seven-year-old boy, “Since 
the mutism [of this boy] was restricted to contacts with a 
(subconsciously) chosen group of people, I would like to 
propose the name elective mutism to designate it” [15]. In 
Tramer’s view, children with this diagnosis are not apha-
sic, but deliberately choose to remain silent [15, 16]. And 
yet, almost as an afterthought, he also mused that the boy 
described in his paper had made a “catatonia-like impres-
sion” during his phases of mutism [15].
Even though Tramer’s contribution only consisted of 
a case report, the term elektiver Mutismus was eventually 
adopted almost universally. It made its first entrance in the 
English literature as ‘elective mutism’ (EM) when Salfield 
[17] published a case report of another 7-year-old boy who 
never spoke at school. Salfield suggested that the problem 
might well have been related to a malfunctioning family 
system, a sociodynamic interpretation that was in vogue 
at that time [18–23], but had already been suggested as a 
possible mechanism by Tramer [15]. Perhaps the principal 
merit of Tramer’s paper was that it included such a schol-
arly overview of the mechanisms thought to be underlying 
the problem, ranging from hereditary factors and delayed 
phases of normal child development (‘being mummyish’) to 
psychological factors (e.g., shyness, hypersensitivity), social 
mechanisms (e.g., social anxiety, early childhood trauma, 
learned behavior in reaction to external pressure), physical 
conditions (e.g., surgery), and major psychopathology (e.g., 
oligophrenia, schizophrenia, catatonia). Even therapeuti-
cally, Tramer showed himself ahead of his time, preluding 
on many of the behavioral techniques that would later be 
advocated by psychotherapists for treating children with SM 
[16, 24–27].
Quantitative empirical research in the field of EM 
remained sparse in the following decades. Only eight stud-
ies had examined samples of 10 or more children with EM 
prior to 1991 [28]. Moreover, research on this topic had been 
using widely varying diagnostic criteria and adopted differ-
ent explanatory models of the condition [29]. As noted by 
Tancer [9], this may have led to the grouping together of 
children with heterogeneous types of underlying pathology, 
and hence to (partly) conflicting descriptions of EM in the 
literature. There were even studies in which these children 
were labeled as passive-aggressive, stubborn, manipula-
tive, oppositional, and/or controlling [18, 19, 22, 23, 28], 
although others described them the way Tramer [15] had 
done, i.e., as being overly shy, dependent, anxious, and/or 
hypersensitive [17, 25, 26, 30, 31].
EM was first included as a diagnostic category in the 
DSM-III, under the general heading of Other Disorders of 
Infancy, Childhood, or Adolescence [32]. In conformity with 
its overall ‘atheoretical’ approach, the DSM Task Force for 
DSM-IV decided to replace ‘Elective Mutism’ by ‘Selec-
tive Mutism’ (SM), thus expressing the notion that this type 
of mutism is found in specific contexts rather than being 
(necessarily) self-chosen [33]. Along with this terminologi-
cal change, a growing number of researchers began to sug-
gest that SM may be primarily related to anxiety [2, 34–38], 
and should therefore be relocated to the group of anxiety 
disorders. Black and Uhde [2] were among the first to pro-
vide support for this claim when they found that 97% of the 
children with SM also met the diagnostic criteria for either 
social phobia or avoidant personality disorder. A substantial 
number of empirical studies reporting that symptoms of anx-
iety are indeed often present in children with SM have since 
been published [7, 39–42]. Therefore, the plan to reclassify 
SM as an anxiety disorder was effectuated in the DSM-5 [1].
The relationship between SM and anxiety was reviewed 
by several authors, including Muris and Ollendick [41], who 
concluded that both conditions tend to overlap in terms of 
symptomatology, etiology, and treatment approaches. How-
ever, the precise nature of this relationship is still insuffi-
ciently clear. A latent-profile analysis by Cohan et al. [7] 
revealed three subtypes of SM, each indicating a clinically 
significant presence of social anxiety. Several studies even 
reported significantly higher observer ratings of anxiety 
for children with SM in comparison to children with social 
phobia [43–45], although this finding has not been docu-
mented in all studies [46, 47]. Moreover, children diagnosed 
with SM do not report higher levels of anxiety than chil-
dren with social phobia on self-report measures [43, 44, 
47, 48], nor do they display higher levels of anxiety when 
measured with the aid of psychophysiological assessment 
instruments [45]. Perhaps these contradictory findings are 
caused by an observer bias in which the observers seek to 
attribute mutism to (social) anxiety [43, 44]. Even though 
the overlap between SM and social phobia appears to be 
high, surprisingly low rates of comorbid social phobia have 
also been reported [49, 50], although part of the children 
in these studies had been diagnosed with other comorbid 
anxiety disorders. As a matter of fact, comorbid diagnoses 
of anxiety disorder other than social phobia are commonly 
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reported in children with SM, including specific phobia [46, 
50] and separation anxiety disorder [8, 51].
Remarkably however, anxiety—as a symptom—does not 
appear in the DSM’s diagnostic criteria for SM (Table 1), 
despite its reclassification as an anxiety disorder. As a 
consequence, perhaps, its presence has not always been 
assessed systematically in empirical studies of individuals 
diagnosed with SM. Instead, researchers have often sought 
to corroborate the link between SM and anxiety by focusing 
on the presence of comorbid anxiety disorders. This is not 
as plausible as it may sound, since an additional comorbid 
diagnosis of social anxiety disorder may indeed be sugges-
tive of a common mechanism underlying the two disorders, 
whereas, for example, a specific phobia for spiders does not 
necessarily say something about one’s reluctance to speak in 
specific social situations. Nonetheless, since direct assess-
ments of levels of anxiety in SM are extremely rare, the body 
of literature on comorbid anxiety disorders in SM may cur-
rently be the best proxy for establishing a link between SM 
and anxiety. To actually assess the strength of this link, the 
present study makes use of a meta-analysis. Its main purpose 
is to provide an overall estimation of the prevalence rate of 
comorbid anxiety disorders in children with SM.
Method
Search Strategy
A systematic search was performed to identify all empiri-
cal studies pertaining to the topic of SM. Historically, the 
terms “elective mutism”—and later—“selective mutism” 
have been used almost exclusively to refer to this psychiatric 
disorder, and were correspondingly adopted by diagnostic 
classification systems such as the ICD and the DSM. We 
therefore argued that the inclusion of these two terms alone 
in our search query should provide a scope broad enough to 
capture all potential publications in this field of research. 
Accordingly, the digital databases Web of Science, PubMed, 
PsycINFO, Embase, and Picarta were searched from their 
inception through March 2019 using the following search 
query: ‘[elective OR selective AND mutism]’. Our search 
strategy was supplemented by backward searches in which 
the reference lists of the retrieved papers were screened for 
publications that were not detected by the initial search.
Study Selection Procedure
All obtained references were stored and managed in End-
Note X9 software. Duplicate records were identified and 
carefully removed from the initial search result. The first 
author (JD) explored all unique references by screening 
the titles and applying filters on record properties, such as 
language, keywords, and type of resource. Publications not 
written in English were excluded, along with resources that 
were clearly unsuitable for inclusion in the meta-analysis 
(e.g., book reviews or commentaries). Non-peer-reviewed 
resources (e.g., conference abstracts or dissertations) were 
also excluded, in order to maintain the scientific value of 
the results derived from our meta-analysis. All remaining 
records were subjected to abstract-review. A reference was 
considered potentially relevant when there was an indica-
tion of a sample of individuals diagnosed with SM being 
described in the paper. Potentially relevant papers that were 
selected were subsequently full-text reviewed to determine 
if they met the following criteria for eligibility: (i) the study 
reported on a sample of individuals diagnosed with SM; (ii) 
the researchers reported the necessary data for extraction—
particularly those related to comorbid anxiety—or provided 
these after a request hereto via email; (iii) the study reported 
original data on individuals diagnosed with SM. Full-text 
reviews were carried out by two authors (JD and MLM) 
independently, with disagreements being resolved through 
discussion until consensus was reached.
Data Extraction
The following data was extracted from eligible studies: 
(i) year of publication; (ii) country and setting of recruit-
ment; (iii) number of participants; (iv) distribution of sex 
Table 1  Current diagnostic criteria for selective mutism as described in the DSM-5 [1]
Diag-
nostic 
criteria
312.23 (F94.0)
A. Consistent failure to speak in specific social situations in which there is an expectation for speaking (e.g., at school) despite speaking 
in other situations
B. The disturbance interferes with educational or occupational achievement or with social communication
C. The duration of the disturbance is at least 1 month (not limited to the first month of school)
D. The failure to speak is not attributable to a lack of knowledge of, or comfort with, the spoken language required in the social situation
E. The disturbance is not better explained by a communication disorder (e.g., childhood-onset fluency disorder) and does not occur 
exclusively during the course of autism spectrum disorder, schizophrenia, or another psychotic disorder
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and age among the sample; (v) diagnostic criteria and 
instruments used to diagnose SM; (vi) prevalence rates of 
comorbid anxiety disorders. Data extraction was initially 
performed by the first author (JD). In order to enhance the 
quality of the collected data, a second researcher (MLM) 
extracted data from a random subset of 25% of the eligible 
studies and blindly checked both extractions for accuracy. 
Possible discrepancies in extracted data were resolved by 
consensus between the two authors.
Quality Assessment
All eligible studies were assessed for their methodo-
logical quality using the Newcastle-Ottawa Scale (NOS) 
[52]. Since we performed a meta-analysis of prevalence, 
research methodology with respect to sample selection and 
baseline assessment were deemed most relevant for qual-
ity evaluation. We therefore adapted the NOS to focus on 
these aspects only (see Online Supplement for our modi-
fied version). The maximum quality assessment score 
of 12 points corresponded to excellent methodological 
quality, whereas a score of 0 indicated poor methodologi-
cal quality. Assessment of quality was performed by two 
authors independently (JD and MLM). Agreement regard-
ing this assessment proved to be good among the two inde-
pendent raters (Cohen’s Kappa [κ] = 0.67; Standard Error 
[SE] = 0.059).
Calculation of Comorbid Anxiety
Studies had to report on the presence of comorbid anxiety 
disorders as established with the aid of validated instruments 
in order to be included in the meta-analysis, such as (semi-) 
structured interviews. We did not discriminate with regard 
to severity, type or number of anxiety disorders that were 
diagnosed in children with SM. Whenever an indicator of 
anxiety among the sample was reported, then this proportion 
was directly implemented. However, most studies reported 
only frequencies of additionally diagnosed comorbid anxi-
ety disorders. Studies were excluded from the meta-analysis 
when we were unable to ascertain the true proportion of 
anxiety and/or the presence of comorbid anxiety disorders, 
either through calculation or through a request via email 
to the original authors. Exceptions were made for studies 
in which a diagnosis of one type of anxiety disorder was 
highly overrepresented in the study sample, while the sum 
of diagnosed anxiety disorders did not exceed the sample 
size. Under these conditions, we argued that using the sum 
of additionally diagnosed anxiety disorders was sufficient to 
determine the total proportion of comorbid anxiety disorders 
in the study sample.
Statistical Analysis
All statistical calculations were performed using Metafor, 
a meta-analysis package for R Statistics Software [53, 54]. 
We employed a random-effects meta-analysis to estimate the 
aggregate prevalence rate of comorbid anxiety disorders in 
children with SM. A restricted maximum-likelihood estima-
tion was used in the model, since this estimator is efficient 
and approximately unbiased [55]. Variance was stabilized 
using a double-arcsine transformation [56, 57], which is the 
preferred method when prevalence rates are used as a varia-
ble in meta-analyses [58]. The results were back-transformed 
for interpretational purposes.
Possible heterogeneity was assessed for statistical sig-
nificance using the Q-statistic and evaluated using I2. High 
values of I2 indicate increased between-study heterogene-
ity [59], in which case a meta-regression analysis would be 
performed to explore for possible moderating effects. We a 
priori specified potential moderators, which included age, 
gender, year of publication, and methodological quality. We 
controlled for Type-I-error rate using the Knapp and Har-
tung adjustment [60], which shows higher power rates and 
better correction to the nominal significance level than the 
standard method [61, 62].
Publication bias refers to the observation that studies 
yielding significant results are more likely to be published 
than studies yielding null results [63]. Assessment for pub-
lication bias was deemed not of interest in the context of our 
meta-analysis, since prevalence rates were used as a variable 
rather than outcome measures. That is to say, we assumed 
that publication in the field of SM would not depend on 
the observed prevalence of comorbid anxiety disorders, as 
it is unlikely that studies manipulated variables in order to 
achieve a certain prevalence rate of comorbid anxiety dis-
orders in their sample. Therefore, null findings are likely 
nonexistent when prevalence rates are used as a variable, 
which makes it redundant to assess for publication bias.
Results
Search Results
A flowchart of the study selection procedure is depicted 
in Fig. 1. Our search strategy identified 1044 (k) unique 
records. After a first screening of titles, keywords, and 
resource types, we filtered out 498 of these records, either 
because they were not written in English (k  =  192) or 
because they indicated a type of resource that was consid-
ered unsuitable for inclusion in the meta-analysis (k = 306). 
Abstracts of the remaining 546 references were reviewed 
in order to identify studies examining samples of children 
diagnosed with SM. A total number of 200 abstracts did 
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not mention SM as a main topic of interest, and were there-
fore excluded, although they sometimes did refer to SM in 
one way or another. Most of these excluded articles focused 
on anxiety disorders in general (22%) or on social phobia 
(9.5%). SM was also mentioned in the context of schizo-
phrenia (8.5%), autism (6.5%), linguistic-related dysfunction 
(7%), and a wide range of neurological diseases (15.5%). 
The 346 references that remained after these exclusions 
comprise the entire English peer-reviewed literature on the 
topic of SM as revealed by our search strategy. The major-
ity of these reports consisted of case studies (k = 188) or 
reviews (k = 67), which were unsuitable for meta-analysis, 
and therefore also excluded. Further screening via abstract 
review identified 91 papers reporting on samples of indi-
viduals diagnosed with SM that were retained for full-text 
review, along with one paper that was detected with the 
aid of backward searches [8]. Two authors (JD and MLM) 
independently carried out the full-text reviews for eligibil-
ity. Only minor disagreements occurred, which were easily 
resolved after consensus was reached. Finally, a total of 22 
studies fulfilled the inclusion criteria for eligibility to par-
ticipate in the meta-analysis.
Study Characteristics
All necessary data for meta-analysis was extracted from 
the 22 eligible studies by the first author (JD) and blindly 
checked by a second author (MLM). Following this pro-
cedure, no discrepancies were found. Collectively, the 22 
studies comprised a combined sample size of N = 837 
children diagnosed with SM. The majority of the total 
sample was female (n = 499), and the average age was 
8.2 years (SD = 3.14; k = 20; two papers did not report 
on this). Table 2 provides an overview of the demographic 
and clinical characteristics of the children included in these 
22 studies. With respect to sample selection, most children 
had been recruited from school-based communities and/or 
clinics specialized in child psychiatry. A diagnosis of SM 
was generally ascertained with the aid of a (semi-)struc-
tured interview with the parents of the participating child. 
All studies relied on DSM-IV diagnostic criteria, except 
for one study that used ICD-10 criteria [64]. More detailed 
information regarding the recruitment and assessment strate-
gies is provided in the online supplement (Table S1). Eligi-
ble studies were evaluated for their methodological quality 
using an adapted version of the NOS. The average quality 
rating of the included studies was 58.2% of the maximum 
score (M = 6.9; SD = 2.21). Items related to sampling meth-
odology had an average rating of 52% (M = 3.1; SD = 1.34), 
whereas items related to baseline assessment had an aver-
age quality rating of 64% of the maximum score (M = 3.8; 
SD = 1.58).
Meta‑analysis
The results of the primary meta-analysis are pre-
sented in Table 3 and depicted in Fig. 2. The harmonic 
mean proportion of children diagnosed with at least 
one additional (comorbid) anxiety disorder was 0.80 
(95% CI = 0.68, 0.89). Considerable heterogeneity in 
Fig. 1  Flowchart of the study 
selection procedure in (k) num-
ber of publications
Initial Search Result
(k = 2,171)
Unique Records
(k = 1,044)
Excluded Abstracts
(k = 455)
Ineligible Papers
(k = 70)
Excluded Records
(k = 498)
Conf. Abstracts (k = 87)
Dissertations (k = 35)
Books & Sections (k = 110)
Book Reviews (k = 25)
Commentaries (k = 42)
Non-English (k = 192)
Other (k = 7)
Case Studies (k = 188)
Reviews (k = 67)
Non-SM (k = 200)
Unavailable (k = 9)
Duplicate Sample (k = 17)
ANX Not Measured (k = 23)
ANX Insuf. Reported (k = 21)
Removed Duplicates
(k = 1,127)
Abstracts Reviewed
(k = 546)
Full-Texts Reviewed
(k = 91)
+1 manually identified
Eligible for Meta-Analysis
(k = 22)
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prevalence figures was observed between the studies 
(I2 = 92.70, p <0.001). Prevalence rates for specific types 
of anxiety disorder among children with SM indicate that 
social phobia (i.e., social anxiety disorder) was the most 
commonly reported anxiety disorder across all studies 
(0.75, 95% CI = 0.56, 0.90). However, this outcome may 
be prone to bias due to missing data, as three studies did 
not specify the proportion of children with an additional 
diagnosis of social phobia. We therefore performed an 
imputed case analysis in which these missing values were 
filled in under the assumption that 75% of the children 
with comorbid anxiety disorder in these three studies had 
actually been diagnosed with social phobia. The imputed 
case analysis resulted in an aggregate prevalence rate of 
Table 2  An overview of the 
eligible studies, including 
sample characteristics and 
reported prevalence rates of 
anxiety disorders
ANX anxiety disorders, SOP social phobia, SAD separation anxiety disorder, SPH specific phobia, GAD 
generalized anxiety disorder, OCD obsessive-compulsive disorder, QR quality rating expressed as a propor-
tion of the maximum score
a The total proportion of comorbid anxiety disorders is determined by the sum of single anxiety disorders
Study N Gen-
der
Age Anxiety disorders (%) QR
M F M (SD) ANX SOP SAD SPH GAD OCD
Alyanak et al. [65] 26 11 15 8.11 (2.1) 73.1 61.5 23.1 0.58
Andersson and Thomsen [64] 37 20 17 9.43 (3.8) 59.5a 45.9 8.1 0.0 8.1 0.50
Arie et al. [66] 18 8 10 8.89 (1.9) 50.0a 44.4 5.6 0.46
Bar-Haim et al. [67] 16 5 11 8.21 (3.5) 87.5a 62.5 0.29
Black and Uhde [2] 30 9 21 8.40 (2.0) 96.7 96.7 16.7 10.0 3.3 0.75
Carbone et al. [39] 37 18 19 8.20 (3.4) 75.6 18.2 13.6 29.5 2.3 0.38
Chavira et al. [51] 70 26 44 6.37 (2.5) 100.0 100 40.0 11.4 8.6 0.63
Cholemkery et al. [46] 43 26 17 11.09 (3.9) 44.2 4.7 32.6 0.88
Dummit et al. [68] 50 14 36 8.20 (2.7) 100.0 100 26.0 14.0 0.88
Edison et al. [49] 21 13 8 33.3 14.3 14.3 14.3 0.33
Gensthaler et al. [69] 95 47 48 9.70 (4.5) 93.7 93.7 20.0 21.1 5.3 0.58
Henkin et al. [70] 10 3 7 9.35 (2.6) 70.0a 60.0 10.0 0.42
Kristensen et al. [3] 54 22 32 9.00 (3.4) 74.1 66.7 31.5 13.0 13.0 9.3 0.88
Lang et al. [71] 24 12 12 6.40 (3.1) 100.0 100.0 41.7 45.8 4.1 0.58
Levin-Decanini et al. [72] 48 13 35 6.53 (2.6) 58.3 6.3 0.71
Manassis et al. [40] 44 12 32 7.87 (1.6) 63.6a 61.4 2.3 0.75
Mulligan et al. [8] 142 52 90 29.6 0.50
Nowakowski et al. [50] 14 6 8 6.36 (0.9) 50.0 0.0 21.1 21.1 0.29
Oerbeck et al. [73] 24 8 16 6.50 (2.0) 100.0 100.0 29.2 25.0 8.3 8.3 0.75
Vecchio and Kearney [42] 15 7 8 6.58 (1.9) 100.0 100.0 40.0 20.0 6.7 0.0 0.67
Vecchio and Kearney [74] 9 2 7 6.60 (1.9) 100.0 100.0 22.2 22.2 11.1 0.54
Young et al. [45] 10 4 6 7.00 (1.8) 80.0 80.0 0.0 0.0 0.0 0.46
Table 3  Results of the meta-
analysis for the prevalence of 
(comorbid) anxiety disorders in 
children diagnosed with SM
ANX anxiety disorders, SOP social phobia, SAD separation anxiety disorder, SPH specific phobia, GAD 
generalized anxiety disorder, OCD obsessive-compulsive disorder
a 0.69 after imputed case analysis CI (95% CI = 0.52, 0.84)
Meta-analysis k Random-effects Heterogeneity
Prevalence CI (95%) Q p I2 (%)
ANX 22 0.80 [0.68, 0.89] 372.79 < 0.001 92.70
SOP 19 0.75a [0.56, 0.90] 348.98 < 0.001 95.29
SAD 18 0.18 [0.12, 0.24] 49.26 < 0.001 64.77
SPH 12 0.19 [0.12, 0.28] 34.65 < 0.001 69.24
GAD 13 0.06 [0.04, 0.09] 15.58 0.21 28.56
OCD 6 0.06 [0.03, 0.10] 2.71 0.74 0.00
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0.69 (95% CI = 0.52, 0.84) of children with SM who were 
also diagnosed with social phobia.
Moderator Analysis
The heterogeneity in the prevalence rates of comorbid anxi-
ety disorders among studies in the meta-analysis was consid-
ered very high [59]. In an attempt to explore the sources of 
this between-study heterogeneity, a moderator analysis was 
conducted by means of a mixed-effects-model meta-regres-
sion. A priori potential moderators included the mean age of 
the sample, the proportion of female participants, the year 
of publication, and the methodological quality of the study 
at hand. However, results of the meta-regression indicated 
that none of the moderating factors had a significant effect 
on the presence of comorbid anxiety disorders.
Discussion
To our knowledge, the association between SM and anxi-
ety (as a symptom) has never been investigated through a 
meta-analytic approach, despite its reclassification as an 
anxiety disorder in the DSM-5. The present study sought 
to examine the supposed link between SM and anxiety by 
means of a meta-analysis. Since levels of anxiety in chil-
dren diagnosed with SM have not always been assessed 
systematically throughout the literature, data on comorbid 
anxiety disorders in SM was judged to be the best substi-
tute for examining this relationship. Hence, the main pur-
pose of the present study was to provide an overall estima-
tion of the prevalence rate of comorbid anxiety disorders 
in children with SM on the basis of meta-analytic data.
A total of 22 studies met the eligibility criteria for 
inclusion in the meta-analysis, comprising data on 837 
children diagnosed with SM. The results indicated that 
80% of these children were additionally diagnosed with 
at least one comorbid anxiety disorder. Social phobia (i.e. 
social anxiety disorder) was found present in 69% of the 
children with a diagnosis of SM, making it the most com-
monly diagnosed comorbid anxiety disorder. This was 
followed by specific phobia (19%), separation anxiety 
disorder (18%), generalized anxiety disorder (6%), and 
obsessive-compulsive disorder (6%). By and large, these 
figures are in line with the observation made in the DSM-5 
that, “In clinical settings, children with selective mutism 
are almost always given an additional diagnosis of another 
anxiety disorder—most commonly, social anxiety disor-
der” (p. 196) [1]. However, they cannot fully support the 
Fig. 2  Forest plot for random-
effects meta-analysis of the 
prevalence of comorbid anxiety 
disorders in children diagnosed 
with SM
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notion that anxiety is always present in SM, as is currently 
implied by its classification as an anxiety disorder.
Etiological Heterogeneity
While diagnoses of comorbid anxiety disorder may account 
for the presence of anxiety in 80% of the children diagnosed 
with SM, it remains unclear how anxiety is manifested in 
the remaining 20% of the children that lacked such an addi-
tional diagnosis. The first and rather obvious reason for 
this is that anxiety does not feature in the DSM-5’s list of 
diagnostic criteria for SM, and that in clinical practice it is 
hardly ever assessed in a direct way. Moreover, the pres-
ence of a comorbid anxiety disorder does not automatically 
imply that SM originates from the same source (i.e., anxi-
ety)—that is to say, not any more than the presence of a 
comorbid depressive disorder would imply that SM would 
be caused by depression. As noted by Tramer as early as 
1934, numerous factors are to be taken into consideration 
if we want to unravel the (probably heterogeneous) etiol-
ogy of SM [15]. Preferably, one would like to investigate 
the presence or absence of these factors in populations with 
SM in a direct way. Regarding anxiety levels, this should 
ideally be done with the aid of validated questionnaires and 
psychophysiological measurements of heart rate, blood pres-
sure, and skin conductance, or some other method to assess 
physiological arousal. Since in clinical practice such assess-
ments are hardly feasible because of the very problem at 
hand (i.e., mutism and uncooperativeness), the assessment 
of comorbid anxiety disorders has been embraced as a lit-
mus test for the presence of anxiety. However, our analysis 
indicates that such comorbid anxiety disorders are undiag-
nosable in 20% of all children with SM. Moreover, among 
the remaining 80% there is a group of no less than 19% with 
a fear for flying, heights, animals, receiving an injection, 
seeing blood, and so on (i.e., specific phobias). One may 
ask oneself whether the anxiety underlying these specific 
phobias is really sufficient to explain a lack of speech in 
front of specific individuals. In sum, by focusing exclusively 
on comorbid anxiety disorders, the DSM would appear to 
restrict its approach to ‘looking where the light shines’. This 
brings us back to Tramer’s observation that the etiology of 
SM is likely to be diverse. When Tancer [9] reviewed the 
literature to facilitate modifications of the diagnostic crite-
ria of SM in the DSM-IV, she argued that the criteria had 
been defined very broadly. Like Tramer [15] before her, she 
expressed the suspicion that this was likely to result in the 
inclusion of children with diverse underlying pathology. 
Consequently, she emphasized that systematic research was 
needed before more specific criteria could be designed. Now, 
more than 25 years later, the number of studies investigating 
samples of children with SM has grown substantially. And 
yet Tancer’s concern remains topical as the DSM criteria of 
SM have not been changed, despite its new classification as 
an anxiety disorder.
Consequences for Classification
Our lack of insight into the full spectrum of etiological 
mechanisms underlying SM has several consequences for 
the classification of SM in the DSM and other taxonomies. 
On the basis of our meta-analysis and subsequent discussion, 
we conclude that we are currently not in a position to estab-
lish with sufficient accuracy whether anxiety plays a key 
role in all cases of SM, or even in a majority of them. From 
that vantage point, it is as yet uncertain how SM should be 
classified (i.e., as a member of the higher-level group of 
anxiety disorders, or perhaps as a member of the groups 
of communication disorders, oppositional defiant disorders 
or neurodevelopmental disorders, to mention some of the 
various possibilities). The so-called ‘atheoretical’ approach 
of the DSM has been much debated, but in conformity with 
this vantage point it might well have been more appropriate 
to stick to the classification of SM as a disorder of infancy, 
childhood, or adolescence (i.e., what is currently called a 
neurodevelopmental disorder in the DSM-5). After all, by 
relocating SM to the group of anxiety disorders, the implicit 
theoretical assumption appears to have been made that anxi-
ety constitutes the disorder’s symptomatological and/or eti-
ological cornerstone. Since the DSM-5 does acknowledge 
the issue of etiological heterogeneity by pointing out the 
influence of temperamental, environmental, genetic, and 
physiological factors, albeit under the heading of Risk and 
Prognostic Factors, it is all the more remarkable that SM 
ended up under the heading of Anxiety Disorders.
That said, the considerable overlap of SM with social 
phobia may also suggest that these two disorders, as defined 
in the DSM-5, are not discrete, separable categories. Psychi-
atric classification is different from biological classification, 
but an analogy may nonetheless be illuminating. For exam-
ple, when defining the housecat as a species, biologists do 
not have the habit of listing all its characteristic features (i.e., 
having fur, walking on four legs, purring when petted, being 
good at ignoring people yet being friendly to others, etc.). 
Instead, they focus on the features that separate housecats 
from the other species within the overarching genus Felis. 
They do not list the features that all cats (including lions, 
tigers, etc.) have, or all mammals have, etc. In the DSM-5, 
“Anxiety Disorders” is a family-level category somewhat 
like “mammal”. In accordance with the principles of biologi-
cal classification, if SM fits under the category of anxiety 
disorders, then persons with SM should also meet the more 
general definition of an anxiety disorder. As a consequence, 
the definitional task here would not be to simply describe 
SM, but, instead, to define whatever characteristics sepa-
rate SM from the other anxiety disorders, especially social 
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phobia [75]. The present study indicates that the current 
DSM definition of SM does not meet this goal. Sticking 
with the example of biological classification, the question 
whether SM is an anxiety disorder, should then become 
whether most children with SM meet the definition of any 
of the higher-level groups of disorders.
SM in Other Age Groups
By focusing almost exclusively on children, the DSM-5 
also precludes the possibility of a proper comparison of SM 
across age groups. Clinical practice teaches us that SM is 
also found in the context of schizophrenia spectrum disor-
ders, catatonia [76], autism [77], and numerous other disor-
ders in adulthood, and even outside the domain of psychopa-
thology, where it may serve as a powerful tool to vent one’s 
misapprehension of—or hostility towards—another person; 
or, alternatively, be an expression of extreme shyness or 
insecurity. Although mutism has been studied in adult popu-
lations, notably in the context of autism and catatonia, there 
is a dire need to focus such studies on the presence of SM 
if we wish to say more about a possible continuum with the 
population targeted by the diagnostic category of SM in the 
DSM-5. As pointed out by Kussmaul as early as 1877, the 
essence of SM appears to be that it is a speech disorder. The 
diagnostic criteria of SM in the DSM-5 seem to be most in 
line with this viewpoint. As a consequence, it may perhaps 
be necessary to revise its current classification as an anxiety 
disorder—at least until empirical research provides us with 
data to back up an alternative choice, and the classificatory 
issues regarding the defining characteristics of higher-level 
groups of disorders and the distinguishing features of lower-
level, individual disorders has been solved.
Limitations
Our results should be viewed in light of several limita-
tions. The initial search strategy identified a large number 
of records that had to be filtered out before abstracts were 
reviewed, which partly included non-peer reviewed mate-
rial, such as conference abstracts and dissertations. Although 
we argue that the exclusion of these resources improved the 
scientific value of our meta-analysis, there is a possibility 
that important data on groups of children diagnosed with 
SM went undetected due to this procedure. The same holds 
for publications not written in English, which comprised 
nearly one-fifth of the records identified by our initial search 
strategy.
Another limitation is the observed heterogeneity of preva-
lence figures, as this impedes the drawing of conclusions 
from the meta-analysis. Heterogeneity between studies is 
likely to arise from sampling errors and/or differences in 
research methodology across studies [59]. In case of the 
current study, these shortcomings may have been amplified 
by the broad scope of our search strategy. That is to say, our 
search query was defined rather broadly in order to cap-
ture all publications pertaining to the topic of SM, while 
the inclusion criteria for meta-analysis made no require-
ments regarding research design or research objective, since 
prevalence rates were used as a variable, rather than out-
come variables. Consequently, different types of study were 
deemed eligible for inclusion in the meta-analysis, which 
likely resulted in varying diagnostic assessment strategies 
among the studies. We did not exclude papers on the basis of 
methodological quality due to the small size of the literature 
on the topic of SM. However, evaluation of methodologi-
cal quality was rated only moderate on average and, indeed, 
revealed varying results across the studies. Although this 
may simply reflect the current state of research in the field 
of SM, sampling errors and differences in research method-
ology were likely present and may thus have contributed to 
the observed heterogeneity.
To deal with this, we explored possible moderating effects 
through meta-regression analysis. Extracted data enabled us 
to include age, proportion of female subjects, and year of 
publication as potential predictors in the equation. Addition-
ally, we included methodological quality as a moderator on 
the basis of the results of the quality assessments. However, 
the results of our mixed-effects meta-regression analysis 
revealed that none of these moderators could explain a sig-
nificant part of the heterogeneity that was observed in the 
meta-analysis.
Recommendations for Clinical Practice and Research
Several recommendations can be made following the 
results of our study. First of all, children with SM should be 
assessed in greater detail with regard to the anxiety-related 
symptoms they may experience, including concrete events 
that are being feared, and the content of associated cogni-
tions. Such an extensive assessment is preferably to be sup-
ported by objective measures (e.g., psychophysiological 
measurements), since subjective assessments made by par-
ents, teachers or clinicians are not sufficient in this respect, 
especially when children with SM remain silent, and may 
not even be in a position to confirm or deny whether any of 
the conclusions tally with their own experiences [45]. Sec-
ondly, we need to broaden the scope of these assessments so 
as to include other factors that might play a role in the etiol-
ogy of SM, including the temperamental, environmental, 
genetic, and physiological factors mentioned in the DSM-5. 
Thirdly, future research could enlarge the target population 
by also including adolescents, adults, and elderly people, in 
whom SM has remained largely unexplored. In the fourth 
place, we advocate the development of standardized ques-
tionnaires and psychophysiological measurements so as to 
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promote the homogeneity between studies and increase over-
all reliability, particularly when clinical anxiety in children 
diagnosed with SM is being examined. Together, these steps 
should help us to elucidate the etiological factors underly-
ing SM. Meanwhile, for as long as these remain uncertain, 
we advocate a revision of the current classification of SM 
to help us prevent making any premature associations with 
anxiety or certain age groups, and also to help us to keep an 
open eye for a possible differentiation of the condition into 
several subtypes.
Summary
Our meta-analysis indicates that SM has a relatively high 
association with comorbid anxiety disorders. Nonetheless, 
it also indicates that the presence of these comorbid disor-
ders fails to validate the presence of an additional anxiety 
disorder in all cases of SM, and that, moreover, the one-
sided focus on comorbid anxiety disorders obscures our 
view of the numerous other etiological factors that may be 
at play. As a corollary, we advocate a substantial broadening 
of our research strategies, a standardization of the assess-
ment tools to be used, and the inclusion of other age groups 
than children alone, to further our understanding of SM. In 
the meantime, to prevent ourselves from jumping to conclu-
sions, we advocate a revision of the current classification 
of SM in psychiatric classifications such as the DSM, and 
maintain focus on its core characteristic—that is failure of 
speech—at least until empirical research has caught up with 
our ideas about the origin of this curious and debilitating 
phenomenon, and several overarching classificatory issues 
have been solved.
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